Work for Vir Biotechnology, Inc.?

Claim Your Profile

Vir Biotechnology, Inc. Logo Image

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. has reached its limit for free report views.

About Vir Biotechnology, Inc.

201-500 Employees
Based in San Francisco, California

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting hepatitis B virus, influenza A, SARS-CoV-2, human immunodeficiency virus and tuberculosis.

Ticker:
VIR
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol